XML 12 R5.htm IDEA: XBRL DOCUMENT v3.3.1.900
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Operating activities    
Net income $ 33,157 $ 8,271
Adjustments, Noncash Items, to Reconcile Net Income to Cash Provided by Operating Activities    
Depreciation, amortization and accretion expense 12,475 10,631
Non-cash accretion of defined stock compensation plan 2,137 2,013
Loss on debt modification and early extinguishment 703 476
Loss on sale of a discontinued operation, before tax 1,039  
Deferred income tax 11,304  
Loss on disposal of fixed assets 1,290 77
Unrealized foreign currency exchange gain (151) (7)
Changes in operating assets and liabilities:    
Accounts receivable (13,045) (26,069)
Inventories (5,719) (9,553)
Prepaid expenses and other current assets (1,130) (2,138)
Income taxes (6,264) 5,132
Accounts payable 1,893 10,347
Accrued expenses 4,057 2,470
Deferred revenue and customer deposits 3,207 2,768
Other liabilities (523) (2,115)
Cash provided by operating activities 44,430 2,303
Investing activities    
Proceeds from sale of a discontinued operation 5,000  
Acquistion of EFT Source, Inc, net of cash   (53,882)
Acquisitions of plant, equipment and leasehold improvements (13,866) (12,676)
Cash used in investing activities (8,866) (66,558)
Financing activities    
Payment of long-term debt (170,929) (9,408)
Proceeds from long-term debt 435,000 60,000
Proceeds from line of credit   11,300
Loan issuance costs (17,773) (440)
Repayment of employee note receivable 108  
Dividend distribution (220,742)  
Payment of deferred IPO cost (2,138)  
Redemption of preferred and common stock (55,992)  
Cash (used in) provided by financing activities (32,466) 61,452
Effect of exchange rates on cash (181) 7
Net increase (decrease) in cash and cash equivalents: 2,917 (2,796)
Cash and cash equivalents, beginning of period 12,941 9,702
Cash and cash equivalents, end of period $ 15,858 $ 6,906